Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics of Inherited Kidney Disorders Laboratory, |
RCV001249150 | SCV001422413 | uncertain significance | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002481603 | SCV002782044 | likely pathogenic | Polycystic kidney disease, adult type | 2024-05-18 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000502935 | SCV000592764 | uncertain significance | Polycystic kidney disease | no assertion criteria provided | clinical testing | The PKD1, p.Phe1146del variant was not identified in the literature nor was it identified in the dbSNP, Clinvitae, ClinVar, GeneInsight COGR, MutDB, ADPKD Mutation Database, PKD1-LOVD, and PKD1-LOVD 3.0, NHLBI GO Exome Sequencing Project and the Exome Aggregation Consortium databases. This variant is an in-frame deletion resulting in the removal of a Phenylalanine residue at codon 1146; the impact of this alteration on PKD1 protein (PC1) function is not known. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. | |
Genome Diagnostics Laboratory, |
RCV001249150 | SCV001977830 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001249150 | SCV001979427 | uncertain significance | not provided | no assertion criteria provided | clinical testing |